L. Seigel

1.1k total citations
11 papers, 478 citations indexed

About

L. Seigel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, L. Seigel has authored 11 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 2 papers in Surgery. Recurrent topics in L. Seigel's work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). L. Seigel is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). L. Seigel collaborates with scholars based in United States. L. Seigel's co-authors include Rogério Lilenbaum, Afshin Dowlati, Sachdev Thomas, Donald G. Albert, Karsten Witt, Rita Axelrod, D. Botkin, Enrique Davila, Michael Schwartz and Mark A. Rubin and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.

In The Last Decade

L. Seigel

11 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Seigel United States	9	307	295	124	49	39	11	478
Carlo Basurto Italy	9	110 0.4×	173 0.6×	155 1.3×	25 0.5×	55 1.4×	20	379
Gralla Rj United States	12	123 0.4×	181 0.6×	128 1.0×	60 1.2×	46 1.2×	29	389
M. González‐Barón Spain	9	67 0.2×	213 0.7×	75 0.6×	31 0.6×	17 0.4×	20	316
Angela Gillbanks United Kingdom	9	76 0.2×	188 0.6×	98 0.8×	55 1.1×	24 0.6×	17	347
M. STOTT United Kingdom	12	267 0.9×	119 0.4×	164 1.3×	15 0.3×	14 0.4×	24	581
Marie T. Bakowski United Kingdom	8	98 0.3×	93 0.3×	78 0.6×	24 0.5×	22 0.6×	11	275
Thomas McFarlane Canada	9	56 0.2×	125 0.4×	108 0.9×	32 0.7×	18 0.5×	19	303
Y. Yataghene France	7	118 0.4×	156 0.5×	75 0.6×	9 0.2×	29 0.7×	15	290
Camille Mazza France	7	263 0.9×	93 0.3×	129 1.0×	14 0.3×	13 0.3×	14	399
Marwan Farouk United States	12	151 0.5×	145 0.5×	319 2.6×	21 0.4×	21 0.5×	18	467

Countries citing papers authored by L. Seigel

Since Specialization

Citations

This map shows the geographic impact of L. Seigel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Seigel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Seigel more than expected).

Fields of papers citing papers by L. Seigel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Seigel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Seigel. The network helps show where L. Seigel may publish in the future.

Co-authorship network of co-authors of L. Seigel

This figure shows the co-authorship network connecting the top 25 collaborators of L. Seigel. A scholar is included among the top collaborators of L. Seigel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Seigel. L. Seigel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Lilenbaum, Rogério, Rita Axelrod, Sachdev Thomas, et al.. (2008). Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2. Journal of Clinical Oncology. 26(6). 863–869. 149 indexed citations

2.

Lilenbaum, Rogério, Luis E. Raez, Jennifer Tseng, L. Seigel, & Enrique Davila. (2008). Efficacy and Safety of Oxaliplatin and Gemcitabine with Bevacizumab in Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(5). 511–515. 22 indexed citations

3.

Lilenbaum, Rogério, Mark A. Rubin, Joyce P. Samuel, et al.. (2007). A Randomized Phase II Trial of Two Schedules of Docetaxel in Elderly or Poor Performance Status Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2(4). 306–311. 30 indexed citations

4.

Lilenbaum, Rogério, Sachdev Thomas, Afshin Dowlati, et al.. (2006). Randomized phase II trial of single agent erlotinib vs. standard chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2. Journal of Clinical Oncology. 24(18_suppl). 7022–7022. 17 indexed citations

5.

Lilenbaum, Rogério, et al.. (2006). Phase II trial of oxaliplatin and gemcitabine with bevacizumab in first-line advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 17009–17009. 13 indexed citations

6.

Lilenbaum, Rogério, Mark A. Rubin, Joyce P. Samuel, et al.. (2004). A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7057–7057. 12 indexed citations

7.

Lilenbaum, Rogério, Mark A. Rubin, Joyce P. Samuel, et al.. (2004). A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7057–7057. 24 indexed citations

8.

Lilenbaum, Rogério, et al.. (2001). Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma. Cancer. 92(8). 2158–2163. 61 indexed citations

9.

Sheridan, Michael J., et al.. (1994). Stage II and III-A non-small cell cancer of the lung: results of surgical resection at Fairfax Hospital.. PubMed. 121(3). 172–8. 1 indexed citations

10.

Pagani, Filippo, et al.. (1993). Stage I non-small cell cancer of the lung results of surgical resection at Fairfax Hospital.. PubMed. 120(3). 146–9. 4 indexed citations

11.

Seigel, L., et al.. (1981). The Control of Chemotherapy-Induced Emesis. Annals of Internal Medicine. 95(3). 352–359. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact